Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
16901
ShcA expression controls EMT-associated cell behavior.
Published 2015“…Error bars show standard error of the mean, based on three independent experiments. (E) Localization of diI-labeled NMuMG cells, either control cells or cells with decreased ShcA expression, in zebrafish, immediately after injection (0 dpi) or at day 3 after injection (3 dpi). …”
-
16902
-
16903
-
16904
-
16905
Age at treatment initiation–cross sex hormones.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
16906
Study characteristics.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
16907
Age at treatment initiation–puberty suppression.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
16908
Search terms.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
16909
PRISMA diagram.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
16910
PRISMA 2020 checklist.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
16911
-
16912
-
16913
Data_Sheet_1_Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.docx
Published 2021“…</p><p>Results: Among the 5 patients, 4 were males ranging from 35 to 80 year old (Mean age = 63 ± 17.87). …”
-
16914
-
16915
-
16916
Identification of Differentially Expressed Genes in the Pheromone Glands of Mated and Virgin <i>Bombyx mori</i> by Digital Gene Expression Profiling
Published 2014“…RNAi-mediated knockdown of putative JH receptor gene, <i>Methoprene tolerant 1</i> (<i>Met1</i>), in female pupa resulted in a significant decrease in sex pheromone production in mature females, suggesting the importance of JH in sex pheromone synthesis.…”
-
16917
Short-delay 5CSRTT testing.
Published 2024“…<p>A) There was a decrease in accuracy in offspring of poly I:C injected rats at the shortest delay of 0.5 s, regardless of genotype. …”
-
16918
-
16919
-
16920
Outline of study participants.
Published 2025“…</p><p>Results</p><p>This study was implemented on 2,688 men and 3,260 women, respectively with the mean (SD) age of 41.5(14.1) and 39.3(13.02) years. …”